Healthcare Technologies (MRM) issues press release on September 2025 KPIs

Rhea-AI Filing Summary

Healthcare Technologies Inc. filed a Form 6-K to notify investors that it issued a press release on October 20, 2025. The release announces the company’s major key performance indicators (KPIs) updated for the month of September 2025 and is attached as Exhibit 99.1.

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

​

FORM 6-K

​

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

​

For the month of October, 2025

​

Commission File Number 001-39809

​

MEDIROM HEALTHCARE TECHNOLOGIES INC.

(Translation of registrant’s name into English)

​

2-3-1 Daiba, Minato-ku

Tokyo 135-0091, Japan

(Address of principal executive office)

​

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

​

​

​

​

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Issuance of Press Release

On October 20, 2025, MEDIROM Healthcare Technologies Inc. (the “Company”) is issuing a press release announcing its major Key Performance Indicators, or KPIs, updated for the month of September 2025. A copy of the press release, dated October 20, 2025, is furnished as Exhibit 99.1 hereto.

The information furnished in this report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.

EXHIBIT INDEX

​

​	​	​
Exhibit No.		Description
99.1	​	Press release of the Company

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​	​	​
​	MEDIROM HEALTHCARE TECHNOLOGIES INC.
Date: October 20, 2025	​
​	By:	/s/ Fumitoshi Fujiwara
​	​	Name: Fumitoshi Fujiwara
​	​	Title: Chief Financial Officer

​

FAQ

What does Healthcare Technologies Inc. (MRM) disclose in this Form 6-K?

The Form 6-K discloses that Healthcare Technologies Inc. issued a press release on October 20, 2025. The release presents the company’s major key performance indicators (KPIs) updated for September 2025 and is furnished as Exhibit 99.1.

Which period do Healthcare Technologies Inc.’s KPIs in the 6-K relate to?

The KPIs mentioned relate to the month of September 2025. Healthcare Technologies Inc. states that its October 20, 2025 press release announces updated major key performance indicators for this specific month, and that release is attached to the Form 6-K as an exhibit.

Is the Healthcare Technologies Inc. (MRM) KPI press release considered filed with the SEC?

The company states the information in this Form 6-K, including Exhibit 99.1, is furnished, not filed. It specifies that this information is not subject to Section 18 liabilities and is not incorporated into other filings unless specifically stated.

What exhibit is included with Healthcare Technologies Inc.’s October 2025 Form 6-K?

The Form 6-K includes Exhibit 99.1, described as a press release of Healthcare Technologies Inc. This press release, dated October 20, 2025, announces the company’s major key performance indicators updated for the month of September 2025.

Who signed Healthcare Technologies Inc.’s October 2025 Form 6-K?

The Form 6-K is signed on behalf of Healthcare Technologies Inc. by Fumitoshi Fujiwara. He is identified in the document as the company’s Chief Financial Officer, signing the report dated October 20, 2025.

Does Healthcare Technologies Inc. use Form 20-F or Form 40-F for annual reports?

The document indicates that Healthcare Technologies Inc. files its annual reports under Form 20-F. This classification reflects its status as a foreign private issuer under U.S. securities regulations.